Cyprotex PLC is a holding company. The Company and its subsidiaries are engaged in the provision of in vitro and in silico Absorption, Distribution, Metabolism, Excretion, Toxicity (ADMET) and Pharmacokinetic (PK) information to the pharmaceutical and biotechnology industries. It offers a range of different services in the areas of ADME-PK, in vitro toxicology, biosciences, in silico prediction, in vitro skin and ocular testing, endocrine disruption and physicochemical profiling. Its in vitro ADME and drug metabolism and pharmacokinetics (DMPK) services include in vitro metabolism, in vitro permeability and transporters, solubility and physicochemical properties, in vitro protein binding and PK and bioanalysis. It operates mainly in North America, Mainland Europe and the United Kingdom. It serves pharmaceutical, biotech, cosmetics, personal care, household products, chemical, agrochemical and tobacco markets. Its subsidiaries include Cyprotex Discovery Limited and Cyprotex US, LLC.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: LON:CRX
- CUSIP: N/A
- Web: N/A
- 50 Day Moving Avg: GBX 158.05
- 200 Day Moving Avg: GBX 139.36
- 52 Week Range: GBX 79.22 - GBX 160.50
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Average Volume: 21,791 shs.
Frequently Asked Questions for Cyprotex plc (LON:CRX)
What is Cyprotex plc's stock symbol?
Cyprotex plc trades on the London Stock Exchange (LON) under the ticker symbol "CRX."
Who are some of Cyprotex plc's key competitors?
Some companies that are related to Cyprotex plc include Partnership Assurance Group PLC (PA), Royal Dutch Shell Plc (RDSB), HSBC Holdings plc (HSBA), Unilever plc (ULVR), British American Tobacco plc (BATS), BP plc (BP), GlaxoSmithKline plc (GSK), AstraZeneca plc (AZN), BHP Billiton plc (BLT), Vodafone Group plc (VOD), Diageo plc (DGE), Lloyds Banking Group PLC (LLOY), Rio Tinto plc (RIO), Barclays PLC (BARC), Reckitt Benckiser Group Plc (RB), Prudential plc (PRU), Shire PLC (SHP) and Glencore PLC (GLEN).
How do I buy Cyprotex plc stock?
Shares of Cyprotex plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
How much does a share of Cyprotex plc stock cost?
One share of Cyprotex plc stock can currently be purchased for approximately GBX 160.50.
Consensus Ratings for Cyprotex plc (LON:CRX) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Cyprotex plc (LON:CRX)
(Data available from 5/24/2015 forward)
|11/17/2015||N+1 Singer||Reiterated Rating||corporate|
Earnings History for Cyprotex plc (LON:CRX)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Cyprotex plc (LON:CRX)
Current Year EPS Consensus Estimate: $6.40 EPS
Dividend History for Cyprotex plc (LON:CRX)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Cyprotex plc (LON:CRX)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Cyprotex plc (LON:CRX)
Latest Headlines for Cyprotex plc (LON:CRX)
Cyprotex plc (CRX) Chart for Wednesday, May, 24, 2017